Pharmaceutical Industry

Stragen Pharma SA 

Plan-Les-Ouates · Since 1981

The core activity of Stragen is the development, manufacture and distribution of pharmaceuticals, particularly niche products for the hospital market, with a focus on the areas of oncology, cardiology, neurology, infectious diseases, antifungals and gynecology.

Straqim Holding SA 

Sion · Since 2018

Straqim Holding SA distributes bulk active pharmaceutical ingredients (APIs) and provides contract manufacturing, sourcing and international supply services for pharmaceutical substances. The company also develops, registers and commercializes ingredients for the consumer health market.

Straqim SA 

Sion · Since 2001

Straqim SA is a Swiss company that distributes bulk active pharmaceutical ingredients (APIs) and develops, registers and commercializes proprietary consumer health ingredients. The company sources APIs through exclusive distribution agreements, manages international supply chains and markets branded consumer health products such as Algalithe, Immunea, Oselan, Prunus4Life and Reginator.

Streefkerk Life Sciences Consultancy (SLSC) 

Dornach · Since 2020

The core activity of SLSC (Streefkerk Life Sciences Consultancy) is to provide consulting and services to small pharmaceutical and biotechnology companies in the areas of: Clinical Development Services, Strategic Development Services, Clinical Pharmacology and Translational Medicine services, Clinical Safety and Medical Monitoring Services, Outsourcing and Vendor Oversight Services, Postmarketing Services, Quality Services, and Training Services. The company supports its clients in the development of medicinal products, compliance with regulatory requirements, and optimization of clinical trials.

Streuli Tiergesundheit AG 

Uznach · Since 2017

The core activity of Streuli Tiergesundheit AG is the supply of Swiss veterinary clinics and veterinary practices with medicinal products, practice consumables, feed supplements, care products and biocides.

Strides Pharma International AG 

Zug · Since 2012

The core activity of Fairmed Healthcare AG is the development, manufacture and distribution of generic and biosimilar medicines, in particular for infectious diseases, as well as the production of active ingredients and finished medicinal products. The company also offers solutions for pharmacies, including the development of its own pharmacy brands.

Stromal Therapeutics AG 

Basel · Since 2018

The core activity of Stromal Therapeutics is the development of new immunotherapies targeting tissue cytokines and their inhibitors produced by stromal cells to heal inflammatory diseases. In particular, the company focuses on the development of therapies for chronic inflammatory diseases, such as inflammatory heart diseases, through the manipulation of the tissue stroma.

SUBSTIPHARM BIOLOGICS SA 

Plan-Les-Ouates · Since 2022

The core activity of Substipharm is the development, manufacture and marketing of pharmaceuticals, including branded and generic products, as well as biological products and vaccines.

SuissTech Engineering AG 

Schlieren · Since 2011

SuissTech Engineering AG is a subsidiary of Omnimedica AG that develops and supplies decontamination agents such as Clinocarbonit®, used to bind and remove radioactive particles (e.g., iodine and cesium) from drinking water and food.

Sumitomo Pharma Switzerland GmbH 

Basel · Since 2016

The company's core activity is the development and improvement of healthcare worldwide through innovative research and development, particularly in the fields of biopharmaceuticals and health technology.

SWAN Isotopen AG 

Bern · Since 2007

The core activity of SWAN Isotopen AG is the production and distribution of radiopharmaceuticals for nuclear medicine, particularly for molecular diagnostics. This includes the development and production of short-lived radiopharmaceuticals as well as the transportation of radioactive materials. The company operates a state-of-the-art production facility on the campus of the Inselspital in Bern and works closely with the University of Bern and other research institutions.

Swedish Orphan Biovitrum AG 

Basel · Since 2014

The company develops and distributes innovative treatments for rare diseases, particularly in the field of hematology, such as hemophilia and immune thrombocytopenia (ITP). The focus is on improving the lives of patients through access to new therapies and promoting patient-centricity and engagement.

Swiss Applied Coating Research (S.A.C.R.) GmbH 

Lugano · Since 2011

The core activity of Swiss A.C.R. Applied Coating Research is the development and production of film coating solutions for the pharmaceutical, nutraceutical and food industries, with a particular focus on natural polymers. The company offers specialized services such as the development of Solid Oral Dosage Forms, Colon-Delivery and Sustained-Release systems, as well as the provision of natural functional polymers for coatings.

Swiss Bioscience GmbH 

Schlieren · Since 2014

The core activity of Swiss Bioscience GmbH is the development and production of pharmaceutical-grade stem cells, particularly human adipose tissue-derived stem cells (hADSCs), under cGMP conditions. The company offers services such as stem cell banking, research and development, and focuses on the application of stem cells in regenerative medicine, particularly for the treatment of age-related diseases.

Swiss Biotech Center SA 

Monthey · Since 2016

The core activity of Swiss Biotech Center is the development and manufacture of biopharmaceutical products, in particular biological medicines, as well as supporting start-ups and companies in the development and marketing of biopharmaceutical products. The company offers services such as research and development, clinical development, manufacturing and marketing of biopharmaceutical products and has an extensive network and expertise in the biotechnology industry.

SwissBiotech SA 

Villeneuve Vd · Since 2001

SwissBiotech SA develops ChondroNest™, a biopolymer-based product for in‑situ reconstruction and regeneration of cartilage extracellular matrix using minimally invasive techniques. The company focuses on tissue-engineering research, prototype characterisation and preclinical testing, and plans to license additional applications such as bone reconstruction and reconstructive/aesthetic surgery to third parties.

Swiss Cannabis Pharma AG 

Stansstad · Since 2022

Swiss Cannabis Pharma AG provides education and training for healthcare professionals on cannabis-based medicinal products and offers expert advisory services. The company also coordinates access to controlled products for authorized prescribers and provides information on applicable regulatory requirements.

swisscann pharma GmbH 

Zurich · Since 2023

swisscann pharma GmbH manufactures and distributes medical cannabis products, including THC-containing preparations for clinical use. The company holds EU‑GMP certification and Swissmedic authorisations for cultivation, controlled-substance handling, manufacturing and GDP wholesale (including import/export), supplying pharmacies, hospitals and pharmaceutical companies in Switzerland and the EU.

swisscann tec AG 

Zurich · Since 2017

swisscann tec AG is a company that produces and distributes THC-containing medical cannabis. It operates an integrated, EU‑GMP‑certified production facility with controlled cleanrooms and modern hydroponic/aeroponic cultivation, and holds Swissmedic approvals for cultivation, controlled-substance handling and GDP for wholesale, import and export, supplying pharmacies, hospitals and pharmaceutical companies.

SWISS CAPS AG 

Kirchberg Sg · Since 2002

SWISS CAPS AG develops, manufactures and analytically tests pharmaceutical softgel capsules and provides manufacturing services for OEB 1–5, including controlled substances. Its services include analytical testing, formulation and process development, product transfer, packaging (e.g. blistering with serialization) and quality/regulatory support.